These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16805215)

  • 1. [Patients with recurrent malignant ventricular arrhythmias--therapeutic challenge].
    Geist M; Rozenman Y
    Harefuah; 2006 May; 145(5):348-9, 398. PubMed ID: 16805215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular tachycardia and ventricular fibrillation.
    Srivathsan K; Ng DW; Mookadam F
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of therapeutic modalities in patients with life threatening arrhythmias.
    Teo KK
    Can J Cardiol; 1994 Apr; 10(3):333-8. PubMed ID: 8162531
    [No Abstract]   [Full Text] [Related]  

  • 4. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques.
    Colella A; Pieragnoli P; Ricciardi G; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-arrhythmic drugs interaction and defibrillation threshold in patients with implantable cardioverter defibrillator].
    de Vasconcelos JT; Galvão Filho Sdos S; Barcellos CM
    Arq Bras Cardiol; 2003 Mar; 80(3):336-9. PubMed ID: 12856278
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of ventricular arrhythmias.
    Aronow WS
    Compr Ther; 2008; 34(2):89-99. PubMed ID: 18833785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).
    ; ; Zipes DP; Camm AJ; Borggrefe M; Buxton AE; Chaitman B; Fromer M; Gregoratos G; Klein G; Moss AJ; Myerburg RJ; Priori SG; Quinones MA; Roden DM; Silka MJ; Tracy C; Smith SC; Jacobs AK; Adams CD; Antman EM; Anderson JL; Hunt SA; Halperin JL; Nishimura R; Ornato JP; Page RL; Riegel B; Priori SG; Blanc JJ; Budaj A; Camm AJ; Dean V; Deckers JW; Despres C; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo JL; Zamorano JL; ; ;
    J Am Coll Cardiol; 2006 Sep; 48(5):e247-346. PubMed ID: 16949478
    [No Abstract]   [Full Text] [Related]  

  • 8. Quinidine: a valuable medication joins the list of 'endangered species'.
    Viskin S; Antzelevitch C; Márquez MF; Belhassen B
    Europace; 2007 Dec; 9(12):1105-6. PubMed ID: 17761793
    [No Abstract]   [Full Text] [Related]  

  • 9. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S; Murawski MM
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
    Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG
    Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram.
    Kyriazis K; Bahlmann E; van der Schalk H; Kuck KH
    Europace; 2009 May; 11(5):665-6. PubMed ID: 19346290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A successfully novel ICD implantation and medical treatment in a child with LQT syndrome and self-limiting ventricular fibrillation.
    Drago F; Fazio G; Silvetti MS; Oricchio G; Michelon G
    Int J Cardiol; 2007 Jun; 118(3):e108-12. PubMed ID: 17408769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brugada syndrome and vasovagal syncope.
    Patruno N; Pontillo D
    Pacing Clin Electrophysiol; 2006 Feb; 29(2):215; author reply 216. PubMed ID: 16492314
    [No Abstract]   [Full Text] [Related]  

  • 14. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrical storm: clinical manifestations and management.
    Littmann L; Rennyson SL
    Minerva Med; 2007 Oct; 98(5):489-501. PubMed ID: 18043559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators.
    Anthony R; Daubert JP; Zareba W; Andrews ML; McNitt S; Levine E; Huang DT; Hall WJ; Moss AJ;
    Pacing Clin Electrophysiol; 2008 Feb; 31(2):144-50. PubMed ID: 18233965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of high defibrillation threshold.
    Uyguanco ER; Berger A; Budzikowski AS; Gunsburg M; Kassotis J
    Expert Rev Cardiovasc Ther; 2008 Oct; 6(9):1237-48. PubMed ID: 18939911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis of idiopathic ventricular fibrillation].
    Buob A; Siaplaouras S; Böhm M; Jung J
    Dtsch Med Wochenschr; 2002 Nov; 127(47):2517-23. PubMed ID: 12444565
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring.
    Goldsmith YB; Liu J; Chou J; Hoffman J; Comenzo RL; Steingart RM
    Am J Cardiol; 2009 Oct; 104(7):990-4. PubMed ID: 19766769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.